ISRCTN11497545
Completed
Not Applicable
tility of 13C-methacetin breath test in predicting long-term survival of patients with decompensated cirrhosis
Health Research Council of Mexican Institute of Social Security0 sites123 target enrollmentMarch 2, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Health Research Council of Mexican Institute of Social Security
- Enrollment
- 123
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28649974
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age above 18 years
- •2\. Diagnosis of decompensated cirrhosis based on history of present illness, clinical and biochemical findings combined with ultrasonographic results, plus liver biopsy when possible
Exclusion Criteria
- •Hepatocarcinoma
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic DecompensationChronic Liver DiseaseNCT02084160Meridian Bioscience, Inc.579
Unknown
Phase 2
¹³C-Methacetin Breath Test (MBT) Methodology StudyHealthy SubjectsChronic Liver DiseaseCirrhosisNCT01205074Hadassah Medical Organization
Terminated
Phase 2
BreathID Multi-center HCV Liver Breath Test StudyHepatitis CNCT00350714Meridian Bioscience, Inc.75
Completed
Not Applicable
Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).Acute Liver FailureAcute on Chronic Liver FailureNCT01946360Institute of Liver and Biliary Sciences, India24
Completed
Not Applicable
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14NASH - Nonalcoholic SteatohepatitisCirrhosisPortal HypertensionNCT03439189Meridian Bioscience, Inc.343